Rockwell Medical (RMTI) Accounts Payables (2010 - 2026)

Rockwell Medical's Accounts Payables history runs 17 years deep, the most recent figure standing at $3.4 million for Q1 2026.

• Quarterly Accounts Payables rose 79.01% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (up 79.01% YoY) and the FY2025 annual result came in at $2.0 million, down 30.32% from the prior year.
• Accounts Payables was $3.4 million for Q1 2026 at Rockwell Medical, up from $2.0 million in the prior quarter.
• Across five years, Accounts Payables topped out at $5.9 million in Q2 2023 and bottomed at $1.5 million in Q2 2025.
• A 5-year average of $3.4 million and a median of $3.3 million in 2024 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2023 — Accounts Payables jumped 101.46% — and 2025, when it sank 60.87%.
• Rockwell Medical's Accounts Payables stood at $4.1 million in 2022, then grew by 11.42% to $4.5 million in 2023, then tumbled by 36.47% to $2.9 million in 2024, then slumped by 30.32% to $2.0 million in 2025, then soared by 72.39% to $3.4 million in 2026.
• Business Quant data shows RMTI's Accounts Payables at $3.4 million in Q1 2026, $2.0 million in Q4 2025, and $1.5 million in Q3 2025.